Search Results - "Schmidt, Peter M"
-
1
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
Published in Neuron (Cambridge, Mass.) (05-01-2006)“…Endocannabinoids are released after brain injury and believed to attenuate neuronal damage by binding to CB 1 receptors and protecting against excitotoxicity…”
Get full text
Journal Article -
2
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels
Published in The Journal of clinical investigation (01-09-2006)“…ROS are a risk factor of several cardiovascular disorders and interfere with NO/soluble guanylyl cyclase/cyclic GMP (NO/sGC/cGMP) signaling through scavenging…”
Get full text
Journal Article -
3
Targeting coagulation factor XII as a novel therapeutic option in brain trauma
Published in Annals of neurology (01-06-2016)“…Objective Traumatic brain injury is a major global public health problem for which specific therapeutic interventions are lacking. There is, therefore, a…”
Get full text
Journal Article -
4
Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses
Published in PloS one (17-08-2011)“…The influenza neuraminidase (NA) inhibitors zanamivir, oseltamivir and peramivir were all designed based on the knowledge that the transition state analogue of…”
Get full text
Journal Article -
5
Nitric Oxide–Independent Vasodilator Rescues Heme-Oxidized Soluble Guanylate Cyclase From Proteasomal Degradation
Published in Circulation research (02-07-2009)“…Nitric oxide (NO) is an essential vasodilator. In vascular diseases, oxidative stress attenuates NO signaling by both chemical scavenging of free NO and…”
Get full text
Journal Article -
6
A generic system for the expression and purification of soluble and stable influenza neuraminidase
Published in PloS one (07-02-2011)“…The influenza surface glycoprotein neuraminidase (NA) is essential for the efficient spread of the virus. Antiviral drugs such as Tamiflu (oseltamivir) and…”
Get full text
Journal Article -
7
Taking down the FLAG! How insect cell expression challenges an established tag-system
Published in PloS one (06-06-2012)“…In 1988 the preceding journal of Nature Biotechnology, Bio/Technology, reported a work by Hopp and co-workers about a new tag system for the identification and…”
Get full text
Journal Article -
8
Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics
Published in BMC biotechnology (15-03-2018)“…Preclinical studies have evaluated haptoglobin (Hp) polymers from pooled human plasma as a therapeutic protein to attenuate toxic effects of cell-free…”
Get full text
Journal Article -
9
Identification of Residues Crucially Involved in the Binding of the Heme Moiety of Soluble Guanylate Cyclase
Published in The Journal of biological chemistry (23-01-2004)“…Soluble guanylate cyclase (sGC), a heterodimeric hemeprotein, is the only receptor for the biological messenger nitric oxide (NO) identified to date and is…”
Get full text
Journal Article -
10
Technical Optimization for the High-Throughput Purification of Antibodies on Automated Liquid Handlers
Published in Methods in molecular biology (Clifton, N.J.) (2021)“…Monoclonal antibodies (mAbs) are the fastest-growing segment in the drug market with eight of the top 20 selling drugs being mAbs and combined sales of close…”
Get more information
Journal Article -
11
Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells
Published in PloS one (17-08-2011)“…In cardiovascular disease, the protective NO/sGC/cGMP signalling-pathway is impaired due to a decreased pool of NO-sensitive haem-containing sGC accompanied by…”
Get full text
Journal Article -
12
Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo
Published in Molecular pharmacology (01-11-2007)“…The ubiquitously expressed nitric oxide (NO) receptor soluble guanylate cyclase (sGC) plays a key role in signal transduction. Binding of NO to the N-terminal…”
Get more information
Journal Article -
13
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent
Published in Blood cells, molecules, & diseases (01-07-2021)“…Hemophilia A and hemophilia B are X-linked inherited bleeding disorders caused by a deficiency of coagulation factor VIII and IX, respectively. Standard of…”
Get full text
Journal Article -
14
Identification of residues crucially involved in soluble guanylate cyclase activation
Published in FEBS letters (24-07-2006)“…The ubiquitous heterodimeric nitric oxide (NO) receptor soluble guanylate cyclase (sGC) plays a key role in various signal transduction pathways. Binding of NO…”
Get full text
Journal Article -
15
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Published in Nature reviews. Drug discovery (01-09-2006)“…Soluble guanylate cyclase (sGC) is a key signal-transduction enzyme activated by nitric oxide (NO). Impaired bioavailability and/or responsiveness to…”
Get full text
Journal Article -
16
Detection of activity of telomerase in tumor cells using fiber optical biosensors
Published in Biosensors & bioelectronics (01-12-2002)“…Human telomerase plays an important role in the cancerogenesis as it is up-regulated in 80–90% of malignant tumors. Thus, it is considered as a potential…”
Get full text
Journal Article -
17
NO- and haem-independent soluble guanylate cyclase activators
Published in Handbook of experimental pharmacology (2009)“…Oxidative stress, a risk factor for several cardiovascular disorders, interferes with the NO/sGC/cGMP signalling pathway through scavenging of NO and formation…”
Get more information
Journal Article -
18
A robust robotic high-throughput antibody purification platform
Published in Journal of Chromatography A (15-07-2016)“…•Two stage robust antibody purification platform has been established.•High yield preparative antibody purification for initial screening…”
Get full text
Journal Article -
19
Optimizing high throughput antibody purification by using continuous chromatography media
Published in Protein expression and purification (01-07-2019)“…The ability to engineer monoclonal antibodies (mAbs) with high specificity made mAbs the fastest growing segment in the drug market. mAbs represent 8 of the…”
Get full text
Journal Article -
20
Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion‐domain stalk
Published in Acta crystallographica. Section F, Structural biology communications (01-02-2019)“…The influenza neuraminidase (NA) is a homotetramer with head, stalk, transmembrane and cytoplasmic regions. The structure of the NA head with a stalk has never…”
Get full text
Journal Article